Skip to main content
Skip to Footer

The Journal of Neuropsychiatry and Clinical Neurosciences

  • Volume 33
  • Number 2
  • May 2021

WINDOWS TO THE BRAIN

Articles

Publication date: 02 December 2020

Pages90–97

Objectives: Pediatric autoimmune neuropsychiatric disorders associated with streptococcal infection (PANDAS) is characterized by the sudden onset of obsessive-compulsive disorder (OCD) and other neurobehavioral symptoms following group A streptococcal ...

https://doi.org/10.1176/appi.neuropsych.20030065

Publication date: 18 November 2020

Pages109–115

Objective: Somatization is thought to underlie functional somatic syndromes (FSSs) and may also contribute to prolonged symptoms after mild traumatic brain injury (mTBI). The investigators evaluated the prevalence of FSSs in patients seeking specialty ...

https://doi.org/10.1176/appi.neuropsych.20060159

Publication date: 28 October 2020

Pages116–123

Objective: Trauma-focused cognitive-behavioral therapy (CBT) is an important component of evidence-based treatment for posttraumatic stress disorder (PTSD), but the efficacy of treatment varies from individual to individual. It is hypothesized that some ...

https://doi.org/10.1176/appi.neuropsych.20030058

Publication date: 02 December 2020

Pages124–131

Objective: Recent research shows that patients with multiple system atrophy (MSA) have significant cognitive and neuropsychiatric comorbidities that can color the clinical presentation of the disease and affect their quality of life. The aims of this ...

https://doi.org/10.1176/appi.neuropsych.20030057

Publication date: 25 February 2021

Pages132–143

Objective: The investigators examined the association of patient-related and headache-related parameters and the effect of medication overuse headache (MOH); the occurrence of depression, anxiety, and stress; and the importance of different domains of ...

https://doi.org/10.1176/appi.neuropsych.20070189

Publication date: 18 November 2020

Pages144–151

Objective: Deep brain stimulation (DBS) is effective for the motor symptoms of Parkinson’s disease (PD). Although most patients benefit with minimal cognitive side effects, cognitive decline is a risk, and there is little available evidence to guide ...

https://doi.org/10.1176/appi.neuropsych.20040077

Analysis and Commentary

Publication date: 14 January 2021

Pages152–156

The behavioral variant of frontotemporal dementia (bvFTD) is the second most common cause of dementia for individuals <65 years old, but accurate diagnosis is often delayed for several years. While previous criteria have increased the ability of ...

https://doi.org/10.1176/appi.neuropsych.20090238

Publication date: 04 February 2021

Pages157–160

Alexithymia is pervasive among psychiatric patients, but its neurobiological mechanism is unclear. Patients with alexithymia cannot “read emotions,” a process involving interoception, or the perception of the body’s internal state, primarily in the ...

https://doi.org/10.1176/appi.neuropsych.20100252

Clinical and Research Reports

Publication date: 25 February 2021

Pages161–166

Objective: Depressive symptoms are a source of significant morbidity in Parkinson’s disease (PD). Electroconvulsive therapy (ECT) is a promising treatment for depression in PD (dPD); however, data remain limited, including data on optimal electrode ...

https://doi.org/10.1176/appi.neuropsych.20050133

Case Reports

Past Issues

View Issues Archive
No.4
View Issue
1 Oct 2024

Vol. 36 | No. 4

No.3
View Issue
1 Jul 2024

Vol. 36 | No. 3

No.2
View Issue
1 Apr 2024

Vol. 36 | No. 2

No.1
View Issue
1 Jan 2024

Vol. 36 | No. 1